Furthermore, clinical analyses were conducted for the sera samples of prostate and breast cancer patients for CRP, cytokines levels (IFN-γ, TNF-α and IL-6), and oxidative stress level markers (MDA and carbonyl contents) (Table 2). This evidence concerns the gene TNF and breast cancer.